Trial Information
Summary: A Study of Long-Term Interferon Therapy in Patients with Hepatitis C
Status: Completed
Protocol Number: 00-DK-0186
Sponsor:
Company Division: Diagnostic
Official Scientific Title: Hepatitis C antiviral long-term treatment against cirrhosis (HALT-C)
Brief Summary: This study will investigate whether long-term antiviral therapy with interferon can prevent liver disease from progressing in patients with chronic hepatitis C infection
Study Phase: N/A
Study Design / Study Details:
- Purpose:
- Allocation:
- Masking:
- Control:
- Assignment:
- Endpoints:
Study Type:
Interventional
Condition: Hepatitis C, Chronic
Intervention Type:
Intervention Name: Amplicor GT HCV Monitor
Primary Outcome:
Key Secondary Outcomes:
Inclusion Criteria:
hepatitis C infection, non-responsive to previous HCV therapy
Exclusion Criteria:
hepatitis B infection
autoimmune hepatitis
HIV infection
intolerant of interferon treatment
Gender: Males or Females
Age Limits: Min: 18 Years Max: 99 Years
Accepts Healthy Volunteers: No
Anticipated Start Date: January, 2006
Trial Registration Date: 03/16/2006
Date Last Updated: 02/07/2008
Link To Trial Results
|
Contact:
Research Site:
Located In:
Irvine, CA 92618
Telephone: 973-235-5000 or 800-526-6367
|
|

This site is run by CenterWatch, a publishing company that focuses on the clinical trials industry. The information provided in this service is designed to help patients find clinical trials that may be of interest to them, and to help patients contact the centers conducting the research. CenterWatch is neither promoting this research nor involved in conducting any of these trials.
Trial listings updated: November 17, 2008 at 2:38:27 PM